About Dan Watkins
Form D filings for Recourse Biologics in 2024 list Dan Watkins as president and co-chief executive officer, director.
Form D filings also name Dan Watkins as an executive officer and director at AskY Therapeutics.
Dan Watkins first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Dan Watkins in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dan Watkins works with at each company, as listed on that company's latest Form D.
Recourse Biologics, Inc. · Form D, Oct 8, 2024
AK
Alexander Krupnick
Director
JW
John Westwick
Executive officer and director
AskY Therapeutics, Inc. · Form D, Jun 4, 2024
AK
Alexander Krupnick
President and director
JW
John Westwick
Director